ofatumumabteriflunomidepwRMSrelapsing multiple sclerosisOMB-OMB
…sess disability outcomes (up to 7 years) of early initiation of ofatumumab treatment versus delayed treatment (after switching from terifl…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…sess disability outcomes (up to 7 years) of early initiation of ofatumumab treatment versus delayed treatment (after switching from terifl…
…n. It is noticed that two patients switched from ocrelizumab to ofatumumab: one due to infusion-related adverse effects and another for lo…
…a vs glatiramer acetate), RIFUND-MS (rituximab vs DMF), TENERE (teriflunomide vs interferon beta) and TRANSFORMS (fingolimod vs interferon be…